Arguably the most famous U.S. shipyard, the Pearl Harbor Naval Shipyard is notable for both its historic role in the country’s entry to World War II and as a source of asbestos exposure. Still a functional military facility today, the Pearl Harbor Naval Shipyard is also a Superfund site where investigations and cleanup activities are
Papermaking and pulp represent one of the largest industries in the world, and the United States accounts for the majority of the world’s consumption of paper. Papermaking has played an important economic and social role in U.S. history, but its contributions came at a cost to paper mill workers exposed to dangerous levels of asbestos contamination.
When malignant pleural mesothelioma is suspected, physicians need to confirm the diagnosis so that they can prescribe the best possible treatment plan. Cytokeratin 5 and 5/6 are important proteins that help to distinguish malignant mesothelioma from pulmonary adenocarcinoma, the most common type of lung cancer. What Is Cytokeratin? Cytokeratin is a type of protein found
Founded in 1887, The American Smelting and Refining Company (ASARCO) grew to encompass mining, smelting, and refining operations until it became a subsidiary of Grupo Mexico in 1999. In 2005, ASARCO filed for bankruptcy protection, and in 2009, the ASARCO Asbestos Personal Injury Settlement Trust was created as part of the ASARCO Chapter 11 Joint
Palliative care has long been known to offer significant benefits to patients suffering from malignant mesothelioma, as well as other advanced cancers. But to date, little has been known about the effectiveness of palliative care delivered virtually rather than in person. Now, a study conducted by Joseph A. Greer, PhD, of Massachusetts General Hospital and
Dr. Rafael Santana-Davila is a medical oncologist who specializes in treating patients with thoracic cancers including lung cancer and malignant pleural mesothelioma, as well as head and neck cancers. He practices at the Fred Hutch Cancer Center in Seattle, Washington, where he holds the titles of Medical Director, Infusion and Pharmacy Services and Associate Professor,
Dr. Mark Onaitis is a thoracic surgeon who specializes in malignant and benign conditions of the chest, including lung cancer, esophageal cancer, thymic malignancies, and malignant pleural mesothelioma. He practices at the University of California San Diego. Dr. Onaitis uses minimally invasive approaches, including thoracoscopy and robotics in his delivery of care. His clinical expertise
Dr. Gasparri is a thoracic surgeon and cardiothoracic surgeon at the Medical College of Wisconsin and Froedtert Hospital Cancer Center in Milwaukee, Wisconsin. He treats patients diagnosed with thoracic malignancies and benign diseases of all kinds, including lung cancer, mediastinal tumors, thymoma, and malignant pleural mesothelioma. Dr. Gasparri is skilled in chest wall reconstruction, minimally
Dr. Christina Brzezniak is a medical oncologist who is board-certified in Medical Oncology, Hematology, and Internal Medicine. She practices in the Reston, Virginia office of Virginia Cancer Specialists where she manages malignancies of all types, with a special interest in the use of immunotherapy for the treatment of malignant pleural mesothelioma and lung cancer. Dr.
Dr. Matt Ballo is a radiation oncologist and the founding chair and chief of Radiation Oncology at the College of Medicine at the University of Tennessee Health Science Center in Memphis, Tennessee. He is also an integral member of the leadership team of the West Cancer Center. His patient care includes the use of innovative